Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1998-10-09
2000-09-12
Jones, Dwayne C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514253, 514410, 514455, 604 21, A01N 5502, A61K 3155
Patent
active
061178624
ABSTRACT:
The invention provides a method to inhibit the formation of neovasculature while maintaining viability of the underlying tissue by subjecting a subject in which angiogenesis is to be inhibited to sublethal photodynamic therapy. The invention also provides a model for assessing sublethal PDT protocols to inhibit angiogenesis in particular target tissues.
REFERENCES:
patent: 4577636 (1986-03-01), Spears
patent: 4727027 (1988-02-01), Wiesehahn et al.
patent: 4753958 (1988-06-01), Weinstein et al.
patent: 4878891 (1989-11-01), Judy et al.
patent: 4932934 (1990-06-01), Dougherty et al.
patent: 5171749 (1992-12-01), Levy et al.
patent: 5368841 (1994-11-01), Trauner et al.
patent: 5756541 (1998-05-01), Strong et al.
patent: 5770619 (1998-06-01), Richter et al.
patent: 5776966 (1998-07-01), North
patent: 5798349 (1998-08-01), Levy et al.
patent: 5807881 (1998-09-01), Leong et al.
Abstract No. XP-002126043 of Circulation Research 76(2):161-167 (1995).
Abstract No. XP-002126044 of Experimental Cell Research 215(2):310-318 (1994).
Abstract No. XP-002126045 of 26th Annual Meeting of the American Society for Photobiology, Snowbird, Utah, USA, Jul. 11-15, 1998 American Society for Photobiology.
W. Gregory Roberts et al., "Role of Neovasculature and Vascular Permeability on the Tumor Retention of Photodynamic Agents," Cancer Research 52:924-930 (1992).
Enrique Mesri et al., "Expression of Vascular Endothelial Growth Factor from a Defective Herpes Simplex Virus Type 1 Amplicon Vector Induces Angiogenesis in Mice," Circulation Research 76(2):161-167 (1995).
Jasminka Vukanovic et al., "Antiangiogenic Effects of the Quinoline-e-Carboxamide Linomide," Cancer Research 53(8):1833-1837 (1993).
Leong Simon
Levy Julia G.
Margaron Philippe Maria Clotaire
Richter Anna M.
Jones Dwayne C.
QLT Inc.
LandOfFree
Model and method for angiogenesis inhibition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Model and method for angiogenesis inhibition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Model and method for angiogenesis inhibition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-96333